Argentina’s healthcare is crumbling under its worst ever dengue epidemic and Milei’s presidency
BMJ 2024; 385 doi: https://doi.org/10.1136/bmj.q896 (Published 23 April 2024) Cite this as: BMJ 2024;385:q896Read the series: Latin America’s global leadership in health
The worst dengue outbreak in the history of the country; a zombie health ministry; hundreds of patients with cancer left without treatment; and the dismantling of academic and scientific infrastructure—the first four months of Javier Milei’s presidency have been dramatic for Argentina.1
Lowering inflation and reducing the fiscal deficit are the number one priorities for Milei and his right wing libertarian party La Libertad Avanza. Milei, a former economist, TV panellist, and sex coach, has reiterated his aim to eliminate universal healthcare.
The government is committed to reducing the power of state departments. One example is the Directorate of Direct Assistance for Special Situations (DADSE), a state institution that provides subsidies for patients with conditions such as cancer, haemophilia, or autoimmune diseases, who cannot otherwise afford treatment. Previously part of the Ministry of Social Welfare (renamed in December as the Ministry of Human Capital), it is now a sub-department of the Ministry of Health. It took until 19 March, 100 days after Milei took office, for a new head of DADSE to be appointed. Services were stopped for three months amid allegations from the new government that DADSE officials had been embezzling funds. The status of the directorate remains unclear; the official process of applying for medical provision has been scrapped but there has been no information for patients about what, if anything, has replaced it.
“DADSE assists many patients who have conditions that could be fatal without treatment,” says Alexis Descourvires, from patient organisation Parents against Glioma. The treatment of DADSE is “inhuman” says Descourvires, leaving many without coverage.
“That has never happened before,” says Carolina Oliveto, general director of the non-profit Argentinean Association of Patients. Oliveto says the number of patients affected is hard to ascertain, but estimates it is at least 400. “The situation is serious—they are letting people die. We don’t know what is going to happen,” she added. On 19 April Milei and the ministers of human capital and health were sued for “abandonment of people,” among other charges in relation to the defunding of DADSE, by Daniel Trava, a lawyer acting independently.2 The case will be heard at a federal court at a date yet to be confirmed.
Dengue epidemic
Amid political change, Argentina, along with many other countries in South America, is suffering from the worst dengue fever outbreak in its history. With over 315 000 reported cases and 238 deaths (to 21 April), Argentina exceeded previous annual records in the first months of 2024.
“There is no leadership,” says Tomás Orduna, the former head of tropical medicine and travel medicine at Hospital Muñiz in Buenos Aires. “There is no plan for mitigating the outbreak, no communication at all, no measures to control the mosquitoes that transmit the virus. This lack of action affects coordination in the provinces. There is no support for hydration units, for example, or mosquito nets for sick people.”
The BMJ contacted the ministry of health but has not had a reply. On 1 April, however, the ministry published a statement blaming the current outbreak on a “lack of preventative measures by the previous government.” Health minister Mario Russo told the media that the ministry works “with a low profile” which should not be confused with inaction.3
Mystery also surrounds the use of Qdenga, a dengue vaccine produced by Japanese pharmaceutical company Takeda and approved for use in Argentina in April 2023. Despite the epidemic, presidential spokesperson Manuel Adorni told the media on 4 March the vaccine’s “effectiveness is not proven.” This statement was disputed by the National Committee of Immunizations—an independent committee of experts reporting to the health ministry—who said it has been proved effective in clinical trials. At the time of writing, Qdenga is available free in three northern provinces—Corrientes, Misiones, and Salta—whose regional governments chose to purchase and distribute the vaccine independent of federal assistance. It is otherwise available to buy privately for $70 a shot—a price out of reach of many citizens—with two jabs required for full immunisation.
A chainsaw to science and the environment
Critics have been relieved that Milei has not, so far, enacted his most extreme campaign promises, such as privatising organ donation and banning abortion (although he repeated his opinion in a March 2024 speech that abortion is “aggravated murder by familial bond”).4
He has, however, taken the “chainsaw,” as he called it in campaigning, to state spending, firing more than 15 000 state employees, leaving services such as national parks and the weather service in turmoil.
There is no longer a ministry of science, its former functions now reduced to a portfolio under Milei’s chief of staff. The budget for the former ministry of science has been frozen at 2023 levels, but with inflation over 100% since December, it marks an effective loss of 50% in real terms.
Many national universities are on the verge of closing because of the sudden halt in state funding. Milei said at a 26 March press conference that public education in Argentina “has done a lot of damage by brainwashing people” with ideas like Marxism.5 The University of Buenos Aires responded in a statement saying that its syllabus is “very similar to that taught in the main universities around the planet” and feared the attack is “mere prejudice, ideological fanaticism, or pure ignorance.”
“There is an official campaign against science and thinking,” says Valeria Levi, a vice dean at the University of Buenos Aires. “The government says that there is no money, but it has announced that will buy military planes from Denmark for $690m—enough to pay 14 years of scholarships. It is not about money, it’s about dismantling all science work in the country.”
Footnotes
Commissioned, not externally peer reviewed.
Competing interests: None.